Never is a long time. I for one think you are wrong on 14 months if all 3 drugs do well they will all male a profit.
APD371 was discovered before the company started? Company started in 1997. I highly doubt they had the drug before they started. Not sure where you guys get this stuff. In 2012 it was listed as Preclinical study.
Charts can be manupulated. You said it was overvalued, so let's see what you are basing value on and do the math. Charts have nothing to do with value. The short term chart is a popularity machine, clearly no one likes or believes in Arena at this time. However, this company can't be valued based on revenue and earnings, we lose money today. We have been a research and development company, we have the promise until we get a drug approved. Today we have 2 approved in 1 in 3 countries, we have a great pipeline in Phase 2. But Mr. Market is betting we will have to raise before results, I for one think they are wrong. Judging from the shorts unwinding they might have changed their minds.
In any event, this is a long term hold and if the drugs are good we go up and if they are proven to not work we will see our value played with. Remember, we stI'll have Belviq and Belviq XR. When the CVOT is complete, it will put to rest any fears doctors MA have for the deug. At that point we will start to generate lots of cash.
Based on what ? How have you valued Belviq, Belviq XR, the Collaberrations with other major drugs, The pipeline and the IP? I would love to see your business valuation with the math behind it.
Tomato tomatoes bad managers/biggest slakers of all. What is your point? To call me a name? Let's get to the meat of my posts, are they accurate and truthful? Do they have merit? They rebuttal you posts just fine. Have a nice day.
Nah, We just need to get through the next 14 month to completion of the clinical studies. Amit and Kevin''s fortunes are tied to ours. Stock options are pegged down here and higher so a sale here or slightly higher is not going to happen. Beacon has limited capital, they are not buying anything. And we control their fate and have an undivideable interest in everything they do going forwars. Instead of guessing call the company, they are much more responsive these days.
please tell what is it you do? I doubt your value to an employer is any where near his. What was you last job paying you? 12 per hour? 15 per hour.
Have you paid attention to the academic studies being done on our drug discoveries? Loracserin has been studied with many positive reviews from private studies. How can you ignore that?
Typical childish personal attacks. Does not change what I posted. Do you understand what EPRS was working on ? They had no real drugs no real candidates. Our drug portfolio is not even in the same galaxy to what they had. Very large established companies have partnered our discoveries and a paying to play. That does not happen with a scam company.
Do you think Amit and Kevin did not do a little DD on the drug candidates before coming here? Kevin comes from private equity and has pharm analysts he has worked with in the past to go over the drugs previous data points. They must believe in them a little bit to tie their rep to this company.
I think my posts and everyone here knows the POV clinical studies need to hit their end points or we will have issues. BUT we stI'll have Belviq and Belviq XR on the market and the CVOT will be completed on just over a year.
Current management is aligned with investors for the first time in a long time. Businessmen are now at the helm.
Where have you been for a year? Jack Lief was retired, new CEO and CFO cutting the fat, focusing the pipeline, showing past bad managers the door. Everything has changed..
Kevin stated they have enough cash to get through all of the slated studies. Both he and Amit's stock options are priced down here, so they have a vested interest in building share value from here. I will believe him over an anonymous Message Board poster that is held to no standards. But thanks for your opinion.
Raising capital is one option but we have so many more options based on the POC Phase 2 clinical study results. Will they raise capital at 1 buck or 9 bucks, will they get a partnership with 200 million up front payments? Will they get a buyout at 9, 12 or 20, or no buyout at all. Only time will tell.
You dogma is moot. The devil is in the details. Does not matter where we have been, the compounds in Phase 2 studies and that have been partnered off, are the results of that money spent. We have the patented drug technology because of those research dollars. The demands on the Belviq studies were much greater then anticipated and that low hanging fruit did not yield the cash flow to build the pipe as expected. The drug works great, but doctors were reluctant to script and out marketing partner did a poor job getting the message out to the public and the doctors. The CVOT will deal with that in just over a year. Then the EU will come on line and the rest of the world will come on line. I just wish we could get a better marketing partner in there.
by tax loss harvesting means pressure on stocks that have not performed. Do not confuse timing and circumstances as signs of Arena going "to zero" or"BK" as many bashes would have you believe. Through out 2017 we will have lots of catalysts so the price should move up into that data and based on the results move appropriately. Good results means higher and of course bad results would move us lower.
Results are expected to be great according to previous studies and indications.
Thar target was based on going into mid year PAH Phase 2 results and the starting of Pain study. 12 month price target not 2 months. We are going into slow time of year for weight loss and tax loss harvesting. That is a normal cycle. Also consider IBB is still off its highs in a large way.
You know that if the data is great we won't need capital or time, we will get bought out for a large premium . Why do you post stuff like that.